SCHEMBL16096735

SCHEMBL16096735

Cc1ccc(C(=O)N(CCCNC(=O)O)[C@@H](c2oc3cc(Cl)ccc3c(=O)c2Cc2ccccc2)C(C)C)cc1

nearest known ligand 0.83

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
KIF11 P52732 5/20 0.83
KCNH2 Q12809 2/20 0.83
MAP1LC3B Q9GZQ8 4/20 0.48
CYP3A4 P08684 1/20 0.48
CYP2C19 P33261 1/20 0.48
PDE6D O43924 4/20 0.44
KIF23 Q02241 1/20 0.37
NAMPT P43490 7/20 0.37
TTR P02766 1/20 0.37
HTT P42858 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25735274 0.95 KIF11 (0.84) KIF11KCNH2MAP1LC3BCYP3A4CYP2C19
SCHEMBL644230 0.92 KIF11 (0.75) KIF11KCNH2MAP1LC3BCYP3A4CYP2C19
SCHEMBL11920179 0.92 KIF11 (0.87) KIF11KCNH2MAP1LC3BCYP3A4CYP2C19
SCHEMBL10192121 0.91 KIF11 (0.79) KIF11KCNH2MAP1LC3BCYP3A4CYP2C19
Sb-743921 SCHEMBL645543 0.91 KIF11 (1.00) KIF11KCNH2MAP1LC3BCYP3A4CYP2C19
Sb-743921 SCHEMBL647316 0.91 KIF11 (1.00) KIF11KCNH2MAP1LC3BCYP3A4CYP2C19
Sb-743921 SCHEMBL29377772 0.91 KIF11 (1.00) KIF11KCNH2MAP1LC3BCYP3A4CYP2C19
SCHEMBL13309222 0.91 KIF11 (0.78) KIF11KCNH2MAP1LC3BCYP3A4CYP2C19
Sb-743921 SCHEMBL16354067 0.90 KIF11 (0.98) KIF11KCNH2MAP1LC3BCYP3A4CYP2C19
Sb-743921 SCHEMBL649759 0.90 KIF11 (0.98) KIF11KCNH2MAP1LC3BCYP3A4CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2968591-A1 CELL PROLIFERATION INHIBITORS AND CONJUGATES THEREOF Novartis AG (CH) 2016-01-20 EP disclosed
WO-2014151030-A1 CELL PROLIFERATION INHIBITORS AND CONJUGATES THEREOF NOVARTIS AG (CH) 2014-09-25 WO disclosed